Form 4: Neeleman Reports HealthEquity Stock Transactions

Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., reported transactions involving common stock and stock options.

Summary

• Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc. (HQY), reported a transaction on March 31, 2026.
• He acquired 9,292 shares of common stock at a price of $82.5264 per share.
• Following this transaction, Neeleman directly beneficially owns 141,227 shares of common stock.
• Additionally, he has indirect beneficial ownership of 409,735 shares held by the Stephen and Christine Neeleman Trust.
• His spouse beneficially owns another 140,000 shares, which Neeleman disclaims beneficial ownership of.
• Neeleman Family Holdings, LLC holds 203,000 shares, with Neeleman acting as manager, though he disclaims beneficial ownership beyond his pecuniary interest.
• The filing also details several stock options, including one with an exercise price of $41.28, exercisable immediately, with 19,897 shares underlying it.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports routine insider transactions and ownership details without indicating significant positive or negative developments for the company's stock.

Positives

• Acquisition of 9,292 shares of common stock by a key executive and director.
• Direct beneficial ownership of a significant number of shares (141,227) by the reporting person.
• The reporting person holds multiple exercisable stock options, indicating potential future equity participation.

Negatives

• The reporting person disclaims beneficial ownership of shares held by his spouse and through Neeleman Family Holdings, LLC, which could indicate a complex ownership structure or a strategic move to limit direct reporting.
• The exercise price of some stock options ($61.72 and $73.61) is significantly higher than the reported acquisition price of common stock ($82.5264), suggesting these options may not be immediately in-the-money if the current market price is below these exercise prices.

Risks

• Potential for future sales of indirectly held shares could impact stock price.
• The disclaimer of beneficial ownership for shares held by family trusts and LLCs could lead to scrutiny regarding control and influence.
• The value and exercise of stock options are subject to market fluctuations and future company performance.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding future financial performance. It primarily details past transactions and current beneficial ownership.

Management Comments

• The reporting person disclaims beneficial ownership of securities held by his spouse and through Neeleman Family Holdings, LLC, except to the extent of his pecuniary interest.
• The stock options are immediately exercisable.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting insider transactions. The details of stock option grants and exercises, as well as the acquisition of shares by executives, are common in the health technology and financial services sectors, where HealthEquity operates.

Related Party Transactions

• Shares held of record by the Stephen and Christine Neeleman Trust.
• Securities beneficially owned by the Reporting Person's spouse.
• Shares held of record by Neeleman Family Holdings, LLC, a Utah limited liability company, where the reporting person is the manager.

Stakeholder Impact

• Shareholders: The acquisition of shares by a key executive can be seen as a positive signal of confidence, but the disclaimed ownership of other shares might raise questions about transparency.
• Employees: The existence and potential exercise of stock options can align employee and executive interests with company performance.
• Management: The filing details the reporting person's direct and indirect holdings, which is standard for executive compensation and ownership disclosures.

Next Steps

• The reporting person may exercise vested stock options in the future.
• Future filings will report any further changes in beneficial ownership.

Key Dates

Keywords

HealthEquity, HQY, Form 4, Insider Trading, Stock Options, Beneficial Ownership, Stephen Neeleman, SEC Filing, Common Stock, Transaction